Literature DB >> 10801983

Presenilin 1 is linked with gamma-secretase activity in the detergent solubilized state.

Y M Li1, M T Lai, M Xu, Q Huang, J DiMuzio-Mower, M K Sardana, X P Shi, K C Yin, J A Shafer, S J Gardell.   

Abstract

gamma-Secretase is a membrane-associated protease that cleaves within the transmembrane region of amyloid precursor protein to generate the C termini of the two Abeta peptide isoforms, Abeta40 and Abeta42. Here we report the detergent solubilization and partial characterization of gamma-secretase. The activity of solubilized gamma-secretase was measured with a recombinant substrate, C100Flag, consisting largely of the C-terminal fragment of amyloid precursor protein downstream of the beta-secretase cleavage site. Cleavage of C100Flag by gamma-secretase was detected by electrochemiluminescence using antibodies that specifically recognize the Abeta40 or Abeta42 termini. Incubation of C100Flag with HeLa cell membranes or detergent-solubilized HeLa cell membranes generates both the Abeta40 and Abeta42 termini. Recovery of catalytically competent, soluble gamma-secretase critically depends on the choice of detergent; CHAPSO (3-[(3-cholamidopropyl)dimethylammonio]-2-hydroxy-1-propanesulfonate) but not Triton X-100 is suitable. Solubilized gamma-secretase activity is inhibited by pepstatin and more potently by a novel aspartyl protease transition-state analog inhibitor that blocks formation of Abeta40 and Abeta42 in mammalian cells. Upon gel exclusion chromatography, solubilized gamma-secretase activity coelutes with presenilin 1 (PS1) at an apparent relative molecular weight of approximately 2.0 x 10(6). Anti-PS1 antibody immunoprecipitates gamma-secretase activity from the solubilized gamma-secretase preparation. These data suggest that gamma-secretase activity is catalyzed by a PS1-containing macromolecular complex.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10801983      PMCID: PMC18571          DOI: 10.1073/pnas.110126897

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  23 in total

1.  Design and synthesis of HIV protease inhibitors. Variations of the carboxy terminus of the HIV protease inhibitor L-682,679.

Authors:  S J deSolms; E A Giuliani; J P Guare; J P Vacca; W M Sanders; S L Graham; J M Wiggins; P L Darke; I S Sigal; J A Zugay
Journal:  J Med Chem       Date:  1991-09       Impact factor: 7.446

2.  A presenilin-1-dependent gamma-secretase-like protease mediates release of Notch intracellular domain.

Authors:  B De Strooper; W Annaert; P Cupers; P Saftig; K Craessaerts; J S Mumm; E H Schroeter; V Schrijvers; M S Wolfe; W J Ray; A Goate; R Kopan
Journal:  Nature       Date:  1999-04-08       Impact factor: 49.962

3.  The proteolytic fragments of the Alzheimer's disease-associated presenilin-1 form heterodimers and occur as a 100-150-kDa molecular mass complex.

Authors:  A Capell; J Grünberg; B Pesold; A Diehlmann; M Citron; R Nixon; K Beyreuther; D J Selkoe; C Haass
Journal:  J Biol Chem       Date:  1998-02-06       Impact factor: 5.157

4.  Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein.

Authors:  B De Strooper; P Saftig; K Craessaerts; H Vanderstichele; G Guhde; W Annaert; K Von Figura; F Van Leuven
Journal:  Nature       Date:  1998-01-22       Impact factor: 49.962

5.  Characterization of new polyclonal antibodies specific for 40 and 42 amino acid-long amyloid beta peptides: their use to examine the cell biology of presenilins and the immunohistochemistry of sporadic Alzheimer's disease and cerebral amyloid angiopathy cases.

Authors:  H Barelli; A Lebeau; J Vizzavona; P Delaere; N Chevallier; C Drouot; P Marambaud; K Ancolio; J D Buxbaum; O Khorkova; J Heroux; S Sahasrabudhe; J Martinez; J M Warter; M Mohr; F Checler
Journal:  Mol Med       Date:  1997-10       Impact factor: 6.354

6.  Evidence that the 42- and 40-amino acid forms of amyloid beta protein are generated from the beta-amyloid precursor protein by different protease activities.

Authors:  M Citron; T S Diehl; G Gordon; A L Biere; P Seubert; D J Selkoe
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-12       Impact factor: 11.205

7.  The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease.

Authors:  J T Jarrett; E P Berger; P T Lansbury
Journal:  Biochemistry       Date:  1993-05-11       Impact factor: 3.162

8.  Familial Alzheimer's disease-linked presenilin 1 variants elevate Abeta1-42/1-40 ratio in vitro and in vivo.

Authors:  D R Borchelt; G Thinakaran; C B Eckman; M K Lee; F Davenport; T Ratovitsky; C M Prada; G Kim; S Seekins; D Yager; H H Slunt; R Wang; M Seeger; A I Levey; S E Gandy; N G Copeland; N A Jenkins; D L Price; S G Younkin; S S Sisodia
Journal:  Neuron       Date:  1996-11       Impact factor: 17.173

9.  Modulation of amyloid precursor protein processing by compounds with various mechanisms of action: detection by liquid phase electrochemiluminescent system.

Authors:  O E Khorkova; K Patel; J Heroux; S Sahasrabudhe
Journal:  J Neurosci Methods       Date:  1998-08-01       Impact factor: 2.390

10.  The presenilin 1 protein is a component of a high molecular weight intracellular complex that contains beta-catenin.

Authors:  G Yu; F Chen; G Levesque; M Nishimura; D M Zhang; L Levesque; E Rogaeva; D Xu; Y Liang; M Duthie; P H St George-Hyslop; P E Fraser
Journal:  J Biol Chem       Date:  1998-06-26       Impact factor: 5.157

View more
  153 in total

1.  Simvastatin strongly reduces levels of Alzheimer's disease beta -amyloid peptides Abeta 42 and Abeta 40 in vitro and in vivo.

Authors:  K Fassbender; M Simons; C Bergmann; M Stroick; D Lutjohann; P Keller; H Runz; S Kuhl; T Bertsch; K von Bergmann; M Hennerici; K Beyreuther; T Hartmann
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-10       Impact factor: 11.205

2.  In search of gamma-secretase: presenilin at the cutting edge.

Authors:  D J Selkoe; M S Wolfe
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

Review 3.  Protein aggregates and dementia: is there a common toxicity?

Authors:  S Lovestone; D M McLoughlin
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-02       Impact factor: 10.154

4.  Presenilin-dependent gamma-secretase activity modulates thymocyte development.

Authors:  P Doerfler; M S Shearman; R M Perlmutter
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-24       Impact factor: 11.205

5.  Activity-dependent isolation of the presenilin- gamma -secretase complex reveals nicastrin and a gamma substrate.

Authors:  William P Esler; W Taylor Kimberly; Beth L Ostaszewski; Wenjuan Ye; Thekla S Diehl; Dennis J Selkoe; Michael S Wolfe
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-26       Impact factor: 11.205

Review 6.  Spotlight on BACE: the secretases as targets for treatment in Alzheimer disease.

Authors:  C Dingwall
Journal:  J Clin Invest       Date:  2001-11       Impact factor: 14.808

7.  Amyloid angiopathy and variability in amyloid beta deposition is determined by mutation position in presenilin-1-linked Alzheimer's disease.

Authors:  D M Mann; S M Pickering-Brown; A Takeuchi; T Iwatsubo
Journal:  Am J Pathol       Date:  2001-06       Impact factor: 4.307

8.  A fluid connection: cholesterol and Abeta.

Authors:  B Wolozin
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-08       Impact factor: 11.205

9.  Presenilin and nicastrin regulate each other and determine amyloid beta-peptide production via complex formation.

Authors:  Dieter Edbauer; Edith Winkler; Christian Haass; Harald Steiner
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-04       Impact factor: 11.205

10.  Comparison of presenilin 1 and presenilin 2 γ-secretase activities using a yeast reconstitution system.

Authors:  Yoji Yonemura; Eugene Futai; Sosuke Yagishita; Satoshi Suo; Taisuke Tomita; Takeshi Iwatsubo; Shoichi Ishiura
Journal:  J Biol Chem       Date:  2011-11-10       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.